Swiss health regulator Swissmedic has approved the coronavirus vaccine from Pfizer/BioNTech. According to the Swiss authorities, the level of protection is over 90% a week after the second dose.
This content was published on
3 minutes
swissinfo.ch/sm
Español
es
Suiza autoriza el uso de primera vacuna antiCOVID-19
Two months after receiving the application, Swissmedic, the Swiss Agency for Therapeutic Products, has given the coronavirus vaccine Comirnaty® (BNT162b2) the green light. Based on the available data, the agency found a comparably high level of efficacy in all age groups that were tested.
“The safety of patients is an essential prerequisite, especially where the authorisation of vaccines is concerned,” said Swissmedic Director Raimund Bruhin in a media releaseExternal link on Saturday. “Thanks to the rolling procedure and our flexibly organised teams, we nevertheless managed to reach a decision quickly – while also fully satisfying the three most important requirements of safety, efficacy and quality.”
More
More
New anti-corona measures: restaurants closed, ski areas open
This content was published on
Switzerland to close restaurants, bars for a month from Tuesday to curb the spread of the coronavirus, ski areas remain open, the government says.
Anyone aged 16 and up can be vaccinated against the novel coronavirus (SARS-CoV-2), subject to compliance with the federal government’s official vaccination recommendations. For optimum protection, Swissmedic suggests two intramuscular injections of the vaccine, spaced at least 21 days apart.
The authorisation application for Comirnaty®, an mRNA vaccine, was submitted in mid-October and reviewed on an ongoing basis (“rolling submission”). The vaccine has already been approved in Britain, Canada, the United States and other countries.
In addition to Pfizer/BioNTech, Switzerland has signed agreements with vaccine manufacturers Moderna and AstraZeneca. The Alpine country now has 15.8 million doses of vaccines on order from the three makers, pending approval from the health regulator. Swissmedic is also evaluating a vaccine from Janssen-Cilag.
First vaccinations in December
The federal government has ordered around three million doses of vaccine from Pfizer/BioNTech. The first 107,000 doses of vaccine will arrive in Switzerland in the next few days, announced the Federal Office of Public HealthExternal link on Saturday.
The Armed Forces Pharmacy will store the vaccine at -70 degrees Celsius before distributing it to the cantons, which can store the vials in refrigerators for a maximum of five days.
Canton Lucerne will launch its vaccination campaign on December 23, starting with vulnerable residents over 65. Basel City will begin on December 28. Nationwide vaccination is slated to start on January 4.
Swissmedic’s vaccine approval came earlier than expected. Though it is good news, it also poses additional challenges for Switzerland’s thinly-stretched healthcare system.
It is up to the cantons to decide how to staff and where to provide vaccination services. Sample locations are medical practices, gymnasiums and military facilities. The estimated two million people in risk groups should be vaccinated first, notes the health office. In addition to senior citizens, that includes people with diabetes, chronic lung disease or high blood pressure.
Next in line are medical workers and relatives of the vulnerable. Swiss health authorities say it will be early spring before other people can be vaccinated.
More than 6,000 people in Switzerland (pop. 8.5 million) have died of Covid-19. Over 400,000 have been infected.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
This content was published on
With a death toll of over 5,000, Switzerland (population 8.5 million) expects to launch its coronavirus vaccination campaign in early January.
Direct trains to run from Zurich to Florence and Livorno
This content was published on
The Swiss Federal Railways and Trenitalia will offer direct trains from Zurich to Florence and Livorno and vice versa from 2026.
Number of Swiss armed forces exceeds specified limit
This content was published on
The Swiss armed forces had an effective headcount of around 147,000 as of March 1, 2024. This exceeds the upper limit of 140,000 specified in the army organisation by 5%.
More than 400,000 cross-border commuters now work in Switzerland
This content was published on
More than half of all cross-border commuters were resident in France (around 57%). Large proportions also lived in Italy (23%) and Germany (around 16%).
Amherd and von der Leyen discuss ongoing Swiss-EU negotiations
This content was published on
Swiss President Viola Amherd and EU Commission President Ursula von der Leyen have met and talked about the ongoing negotiations between Bern and Brussels.
This content was published on
One million francs, 34 million euros and around 830 kilos of gold: this is the fortune that two Swiss nationals are accused of having moved across borders for at least four years.
Girls in female-dominated classes earn more later on
This content was published on
At the age of 30, women from school classes with a 55% share of girls earn $350 more per year than women from classes with a 45% share of girls.
This content was published on
Geneva-based luxury goods group Richemont reported a downturn in performance for the first half of its 2024/25 financial year. Both sales and profit declined.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Emergency vaccine approval not legal option in Switzerland
This content was published on
Emergency approval process used by some countries to speed up the roll-out of Covid-19 vaccines is not a legal option in Switzerland, Swissmedic says.
This content was published on
The Swiss government increased its previous order with the US biotechnology company for its mRNA vaccine to a new total of 7.5 million doses, it was announced on Tuesday. Earlier this week, Switzerland added a vaccine from Pfizer/BioNTech to its desired stockpile list. Switzerland’s membership of the World Health Organization COVAXExternal link initiative would also grant access…
Incomplete data stalls Swiss authorisation of Covid-19 vaccines
This content was published on
Switzerland’s medical regulator says it lacks the necessary information to sign off on three different vaccines ordered by the government.
Can Switzerland convince its people to take the Covid-19 vaccine?
This content was published on
With several vaccines in late stages of development, the next step is to address widespread scepticism so enough people will agree to the jab.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.